Quality of heart failure management: a comparison of care between a comprehensive heart failure program and a general cardiology practice.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Congestive Heart Failure

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1751-7133.2009.00136.xPMID 20412471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacist care of patients with heart failure: a systematic review of randomized trials.

  2008cited by this paper
• Why it Pays for Hospitals to Initiate a Heart Failure Disease Management Program

  2008cited by this paper
• Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction.

  2007cited by this paper
• Association between performance measures and clinical outcomes for patients hospitalized with heart failure.

  2007cited by this paper
• American Heart Association--scientific sessions 2005. 13-16 November 2005, Dallas, TX, USA.

  2006cited by this paper
• Impact of medication therapy discontinuation on mortality after myocardial infarction.

  2006cited by this paper
• The effect of cardiac resynchronization on morbidity and mortality in heart failure.

  2005cited by this paper
• ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society

  2005cited by this paper
• Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry.

  2005cited by this paper
• Risk-treatment mismatch in the pharmacotherapy of heart failure.

  2005cited by this paper
• Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

  2005cited by this paper
• Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

  2004cited by this paper
• Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

  2004cited by this paper
• Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.

  2004cited by this paper
• The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports.

  2004cited by this paper
• Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

  2003cited by this paper
• Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

  2003cited by this paper
• Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

  2003cited by this paper
• PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION

  2002cited by this paper
• Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

  2002cited by this paper
• A systematic review of randomized trials of disease management programs in heart failure.

  2001cited by this paper
• Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

  2001cited by this paper
• How many people with heart failure are appropriate for biventricular resynchronization?

  2000cited by this paper
• Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients

  2000cited by this paper
• Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

  2000cited by this paper
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

  1999cited by this paper
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

  1999cited by this paper
• Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study.

  1999cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Prevention of hospitalizations for heart failure with an interactive home monitoring program.

  1998cited by this paper
• Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

  1996cited by this paper
• Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation.

  1996cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure.

  1995cited by this paper
• First- or second-degree atrioventricular block as a risk factor in idiopathic dilated cardiomyopathy.

  1993cited by this paper
• Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril on the Long‐term: Progression of Left Ventricular Dysfunction in Patients With Heart Failure

  1992cited by this paper
• Prognostic factors in nonsustained ventricular tachycardia.

  1984cited by this paper
• The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.

  1984cited by this paper
• Nurse practitioner role in a chronic congestive heart failure clinic: in-hospital time, costs, and patient satisfaction.

  1983cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Rationale and design of a navigator‐driven remote optimization of guideline‐directed medical therapy in patients with heart failure with reduced ejection fraction

  2019cites this paper
• Medical Inertia in the Optimization of Heart Failure Treatment after Discharge and its Relationship to Outcome

  2018cites this paper
• An exploratory study of the utilization of evidence-based pharmacological treatment on heart failure patients in Mississippi and its impact on readmission

  2017influential citation
• Effectiveness of implementation strategies in improving physician adherence to guideline recommendations in heart failure: a systematic review protocol

  2016cites this paper
• Review of eligibility for cardiac resynchronization therapy.

  2015cites this paper
• Rationale, Design, Methodology and Hospital Characteristics of the First Gulf Acute Heart Failure Registry (Gulf CARE)

  2014cites this paper
• Mortality, morbidity and evidence‐based management amongst patients in regional New Zealand with severe left ventricular systolic dysfunction (1997–2011)

  2013cites this paper
• Gender-related differences in patients with acute heart failure: management and predictors of in-hospital mortality.

  2013cites this paper
• Medical Practice Variations in Heart Failure

  2013cites this paper
• Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed?

  2012cites this paper
• The year in quality of care in heart failure.

  2011cites this paper